Latest Restructuring News

FirstWave Cloud Technology reported a mixed Q3 FY25 with declining cash reserves and ARR but secured a strategic AWS-funded partnership to accelerate cloud service adoption.

MedAdvisor Solutions reported a challenging third quarter with steep revenue declines, driven by delayed program launches and US sales underperformance, but is executing a strategic overhaul and cost-cutting measures to position for a rebound and 15% revenue growth in FY26.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.

Atomos Limited announces a key leadership transition with COO Peter Barber appointed CEO, succeeding co-founder Jeromy Young who will remain on the board as a Non-Executive Director.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

Global Lithium Resources has resumed its Definitive Feasibility Study at the Manna Lithium Project, focusing on cost optimization and project economics, while advancing heritage and native title agreements. The company also reported significant board changes and a robust cash position heading into 2025.

Quickstep Holdings reported a $5.8 million net operating cash outflow in Q3 FY25 but bolstered liquidity by securing $6.6 million in customer advances and implementing cost controls.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

Optiscan Imaging Ltd has revealed its next-generation InForm™ pathology imaging device and strengthened its executive team, while reporting a robust cash position supported by a $1.775 million R&D tax refund for the quarter ended 31 March 2025.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.